European Equities Traded in the US as American Depositary Receipts Fall Sharply in Tuesday Trading
European equities traded in the US as American depositary receipts were moving sharply lower late Tuesday morning, falling 1.21% to 1,404.91 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies (DBVT) and biotech firm BioNTech (BNTX), which rose 2.6% and 2.3%, respectively. They were followed by semiconductor company Sequans Communications (SQNS) and furniture maker Natuzzi (NTZ), which were down 1.5% and 1.4%, respectively.
The decliners from continental Europe were led by telecommunications company VEON (VEON) and medical device maker EDAP TMS (EDAP), which retreated 6.9% and 3.5%, respectively. Biopharmaceutical firm Grifols (GRFS) lost 3.3% and financial services company Banco Santander (SAN) was down 2.8%.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics (AKTX) and TC Biopharm (TCBP), which advanced 8.5% and 3.9%, respectively. They were followed by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Mereo BioPharma Group (MREO), which rose 3.6% and 2.3%, respectively.
The decliners from the UK and Ireland were led by financial services companies Barclays (BCS) and Lloyds Banking Group (LYG), which fell 3% and 2.8%, respectively. Biopharmceutical company NuCana (NCNA) was down 2.6% and financial services company HSBC (HSBC) lost 2.3%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。